We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKE icon
451
Buckle
BKE
$2.25B
$1.79M 0.03%
39,417
-1,521
-4% -$60.1K
UL icon
452
Unilever
UL
$137B
$1.78M 0.03%
25,883
-168,399
-87% -$11.8M
SBH icon
453
Sally Beauty Holdings
SBH
$1.43B
$1.78M 0.03%
+192,162
New +$1.66M
QUAD icon
454
Quad
QUAD
$536M
$1.76M 0.02%
+311,987
New +$1.69M
CPRX
455
DELISTED
Catalyst Pharmaceutical
CPRX
$1.75M 0.02%
80,844
-11,092
-12% -$262K
BKH icon
456
Black Hills Corp
BKH
$5.42B
$1.75M 0.02%
31,264
-3,802
-11% -$223K
IDT icon
457
IDT Corp
IDT
$1.64B
$1.75M 0.02%
+25,626
New +$1.47M
UNTY icon
458
Unity Bancorp
UNTY
$591M
$1.73M 0.02%
36,676
-4,285
-10% -$185K
UVV icon
459
Universal Corp
UVV
$1.31B
$1.73M 0.02%
29,641
-3,553
-11% -$205K
MLAB icon
460
Mesa Laboratories
MLAB
$564M
$1.72M 0.02%
18,287
-1,723
-9% -$189K
EBF icon
461
Ennis
EBF
$552M
$1.69M 0.02%
93,071
+39,762
+75% +$745K
INMD icon
462
InMode
INMD
$870M
$1.68M 0.02%
+116,355
New +$1.71M
PFE icon
463
Pfizer
PFE
$143B
$1.65M 0.02%
68,239
-3,808
-5% -$88.8K
BHRB icon
464
Burke & Herbert Financial Services Corp
BHRB
$1.48B
$1.64M 0.02%
27,424
-3,291
-11% -$182K
CZFS icon
465
Citizens Financial Services
CZFS
$373M
$1.62M 0.02%
27,534
+16,035
+139% +$922K
NUS icon
466
Nu Skin
NUS
$252M
$1.58M 0.02%
+198,006
New +$1.39M
CVS icon
467
CVS Health
CVS
$133B
$1.53M 0.02%
22,200
-7,171
-24% -$470K
MRK icon
468
Merck
MRK
$322B
$1.52M 0.02%
19,239
TTEC icon
469
TTEC Holdings
TTEC
$121M
$1.49M 0.02%
+309,971
New +$1.42M
DXPE icon
470
DXP Enterprises
DXPE
$2.43B
$1.47M 0.02%
+16,785
New +$1.4M
HAE icon
471
Haemonetics
HAE
$3.89B
$1.44M 0.02%
19,346
-2,064
-10% -$137K
AGGY icon
472
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$920M
$1.43M 0.02%
32,881
+517
+2% +$22.3K
CENTA icon
473
Central Garden & Pet Co Class A
CENTA
$2.37B
$1.43M 0.02%
+45,735
New +$1.43M
CORT icon
474
Corcept Therapeutics
CORT
$12.4B
$1.42M 0.02%
19,393
-1,371
-7% -$99.4K
NWN icon
475
Northwest Natural Holdings
NWN
$2.06B
$1.41M 0.02%
35,388
+9,286
+36% +$385K

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.